2018 Global Immunohematology and Infectious Disease NAT Screening: Market Shares by Country, Emerging Assays, Strategic Profiles of Leading Suppliers - ResearchAndMarkets.com

November 26, 2018

DUBLIN--(BUSINESS WIRE)--Nov 26, 2018--The “2018 Global Immunohematology and Infectious Disease NAT Screening: Market Shares by Country, Emerging Assays, Strategic Profiles of Leading Suppliers” report has been added to ResearchAndMarkets.com’s offering.

This report presents a comprehensive analysis of the clinical significance and market needs for major blood typing, grouping, and infectious disease screening assays, including NAT tests, as well as extensive listings of companies developing or marketing new blood banking technologies and products.

The report also presents strategic assessments of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and business strategies.

Key Topics Covered

1. Blood Typing and Grouping Tests

a. ABO

b. Antibody Panels

c. Antibody Screening

d. Antigen Typing

e. Antiglobulin Test

f. Crossmatch

g. HLA Typing

h. Rh

i. Other Blood Groups

2. Blood Group Genotyping

a. PCR



d. Multiplex PCR

e. Real Time PCR

f. Sanger DNA Sequencing

g. Pyrosequencing

h. Microarrays

- BeadChip Array

- BloodChip

- Genome Lab SNP Stream

- Fluidic Microarray Systems

- TaqMan OpenArray


- Mini-Sequencing

3. Infectious Disease Screening Tests


- Structure and Composition

- Classification

- Origin of AIDS

- Animal Lentivirus Systems

- Virus Receptors

- HIV Infections in Humans

-Pathogenesis & Pathology

-Overview of Course of HIV Infection

- CD4T Lymphocytes and Memory Cells

- Monocytes and Macrophages

- Lymphoid Organs

- Neural Cells

- Viral Coinfections

-Clinical Findings

- Plasma Viral Load

- Pediactric AIDS

-Neurologic Disease

-Opportunistic Infections




- Viruses

- Cancer

- Immunity

- Laboratory Diagnosis

-Virus Isolation


-Detection of Viral Nucleic Acid or Antigens

- Epidemiology

-Worldwide Spread of AIDS

-United States

-Routes of Transmission

- Prevention, Treatment, And Control

-Antiviral Drugs

-Vaccines Against HIV

- Transmission of HIV in Blood Products

- HIV Transmission in Transplant and

Artificial Insemination Recipients

- Diagnostic Tests

- Enzyme Immunoassay Interpretation

- Specificity, Sensitivity, and Predictive

Value of Enzyme Immunoassay

- Competition Assays

- Western Blot Technique

- Immuno-Fluorescence Assay (IFA)

- Radioimmunoprecipitation

- HIV-1/HIV-2 Combination Testing

- Methods of HIV-Antigen Detection

- Antigen Assays and Blood Screening

- Urine Tests

- DNA Probes

- Overview

- Quantitative Polymerase Chain Reaction

- In Situ PCR

- Needed Improvements

- Viral Load/Drug Resistance Testing

- Genotype and Phenotype Testing

- Blood Banking Considerations

b. Hepatitis

- Hepatitis A

- Hepatitis B

-Structure and Composition

-Replication of Hepatitis B Virus

- Hepatitis C

- Hepatitis D (Delta Hepatitis)

- Hepatitis E

- Hepatitis G

- Hepatitis Virus Infections In Humans


- Clinical Findings

- Laboratory Features

-Hepatitis A

-Hepatitis B

-Hepatitis C

-Hepatitis D

-Hepatitis E

- Virus-Host Immune Reactions

- Epidemiology

-Hepatitis A

-Hepatitis B

-Hepatitis C

-Hepatitis D (Delta Agent)

- Vaccines and Drugs

c. Cytomegalovirus

- Background

- Chorioretinitis

- Gastrointestinal

- Central Nervous System Disease

- Diagnostic Tests

- Vaccines and Drugs

d. Syphilis

- Background

- Diagnostic Tests

- Vaccines and Drugs

e. West Nile Virus

- Background

- Clinical Syndromes

- Diagnostic Tests

- Vaccines and Drugs

f. Parvovirus B19

- Microbiology

- Epidemiology

- Clinical Syndromes

-Erythema Infectiosum Slapped (cheek)

-Adult Polyarthropathy

-Transient Aplastic Crisis

-Transient Pancytopenia

-Red Cell Aplasia in the Immunocompromised

-Perinatal Infections

- Diagnosis

- Treatment

g. Creutzfeldt-Jakob’s Disease

- Background

- Transmission

- Diagnostic Tests

- Major Commercial and Academic Players


-Disease Sciences/BioTec Global

-Imperial College School of Medicine

-Ortho-Clinical Diagnostics


-ProMetic Life Sciences

-Proteome Sciences/Idexx

-Q-One Biotech


-U.S. Agricultural Research Service

- Drugs

- Vaccines

h. Malaria

i. Chagas Disease

j. Babesiosis

4. Pathogen Reduction

5. Leukocyte Reduction

- Background

- Methods

Companies Featured

Abbott Beckman Coulter/Danaher Becton Dickinson Biokit BioMerieux Bio-Rad CellMark Forensics/LabCorp Diagast DiaSorin Fujirebio Grifols Hologic/Gen-Probe Immucor Ortho-Clinical Diagnostic Proteome Sciences Quest Quidel Roche Siemens Tecan Thermo Fisher/Life Technologies

For more information about this report visit https://www.researchandmarkets.com/research/2h5frm/2018_global?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181126005337/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Infectious Disease Testing



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/26/2018 06:24 AM/DISC: 11/26/2018 06:24 AM


Update hourly